Malignant_and_nonmalignant_T_cell_lines_from_human_T_cell_lymphotropic_virus_type_I-negative_patients_with_Sezary_syndrome._The_establishment_of_an_in_vitro_model_for_cutaneous_T_cell_lymphomas_and_Sezary_syndrome_has_been_difficult_since_T_cells_from_individuals_with_these_diseases_do_not_proliferate_in_response_to_T_cell_mitogens._We_found_that_conditioned_media,_collected_from_mitogen-activated_PBMC_from_Sezary_patients,_contain_an_IL-2_receptor_inducing_factor._Despite_their_ostensible_proliferative_disorder,_using_a_combination_Sezary_cell-conditioned_media_and_rIL-2,_we_established_IL-2_responsive,_human_T_cell_lymphotropic_virus_type_I_negative_T_cell_lines_from_23_patients,_nine_of_which_contain_cells_with_the_structural_and/or_genetic_characteristics_of_neoplastic_Sezary_T_cells.